『What If the Problem Isn’t the Science, but the Business Model? | Episode 2』のカバーアート

What If the Problem Isn’t the Science, but the Business Model? | Episode 2

What If the Problem Isn’t the Science, but the Business Model? | Episode 2

無料で聴く

ポッドキャストの詳細を見る

Board-certified nurse practitioner and longevity practice founder Michelle Beccio breaks down the hidden mechanics of drug approvals, the reality of regulatory capture, and the recent massive policy shift surrounding banned peptides like BPC-157. The hosts also expose the loopholes in medical device approvals and discuss why true longevity care requires stepping outside the traditional insurance model.

Key Topics Covered:

  • The Funding Conflict: How the Prescription Drug User Fee Act (PDUFA) allows pharmaceutical companies to fund the very agency regulating them.
  • Regulatory Capture & Publication Bias: Why negative drug trials quietly disappear and how data gets manipulated.
  • The Peptide Crackdown & Unbanning: What caused the 2023 ban on compounding peptides like BPC-157 and Thymosin Alpha-1, the dangers of black-market online vendors, and the latest policy updates.
  • The 510(k) Loophole: How 95%+ of medical devices hit the market through "daisy chaining" without independent clinical trials.
  • Longevity & Future Tech: The real science behind NAD+, hormone replacement therapy, wearables, and how AI will reshape clinical decision-making.

Our Instagram handles


Michelle Beccio - @michelle_beccio_fnp

Diane Dy - @ddy82

Jennifer Harris - @rootedfunctionalmed


email us at
trilogicapodcast@gmail.com

Here is how to connect with us and inquire about the retreat and wellness offerings email:

pranawellnessretreat@gmail.com

adbl_web_anon_alc_button_suppression_t1
まだレビューはありません